CTGF increased the tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) expression in diabetes, preventing matrix degradation and stimulated EMT in renal tubular cells in diabetes, leading to genesis of new fibroblasts in the renal interstitium [90]. The gene discussed is TIMP1; the disease is diabetes mellitus.